Submitted by Anonymous (not verified) on 24 August 2026 - 13:22
Orphan designation: dinutuximab beta Treatment of Ewing sarcoma, 23/06/2026 Positive
Source:
Orphan designation: dinutuximab beta Treatment of Ewing sarcoma, 23/06/2026 Positive